Academic Journals Database
Disseminating quality controlled scientific knowledge

Biosimilars

ISSN: 2230--245X
Publisher: Dove Press


ADD TO MY LIST
 
Scientific factors for assessing biosimilarity and drug interchangeability of follow-on biologics

Author(s): Chow SC | Endrenyi L | Lachenbruch PA | Yang LY | Chi E
Volume: 2011
Issue: default
Year: 2011
Biosimilars: an overview

Author(s): Bhupinder Singh Sekhon | Vikrant Saluja
Volume: 2011
Issue: default
Year: 2011
Clinical efficacy and safety of XM01, a biosimilar recombinant human erythropoietin, in the management of anemia

Author(s): Mohammed A | Bagalagel A | MacDonald K | Abraham I
Volume: 2013
Issue: default
Year: 2013
Clinical efficacy and safety of Tevagrastim® (XM02), a biosimilar recombinant human granulocyte colony-stimulating factor

Author(s): Bagalagel A | Mohammed A | MacDonald K | Abraham I
Volume: 2013
Issue: default
Year: 2013
Clinical efficacy and safety of SB309, a biosimilar recombinant human erythropoietin, in the management of anemia

Author(s): Bagalagel A | Mohammed A | MacDonald K | Abraham I
Volume: 2013
Issue: default
Year: 2013
Current and future biosimilars: potential practical applications in rheumatology

Author(s): Noaiseh G | Morel | L
Volume: 2013
Issue: default
Year: 2013
Rituximab and biosimilars – equivalence and reciprocity

Author(s): Qureshi ZP | Magwood JS | Singh S | Bennett CL
Volume: 2013
Issue: default
Year: 2013
Similar biotherapeutic products in Latin America. Regulation and opportunities for patients with autoimmune diseases

Author(s): Desanvicente-Celis Z | Caro-Moreno J | Enciso-Zuluaga M | Anaya JM
Volume: 2013
Issue: default
Year: 2013
A European perspective on the market accessibility of biosimilars

Author(s): Declerck PJ | Simoens S
Volume: 2012
Issue: default
Year: 2012
The development and introduction of biosimilar anticoagulants – focus on enoxaparin

Author(s): Ginsberg JS
Volume: 2012
Issue: default
Year: 2012
Affiliate Program      Why do you need a reservation system?